Madrigal Pharmaceuticals Expands Treatment Options for Liver Disease MASH
Madrigal Pharmaceuticals, the first company to get U.S. approval for a medicine treating the common liver disease MASH, is now […]
Big Pharma’s Push for Easier, Faster Cancer Treatments
Big drug companies are working hard to make cancer treatments called CAR-T cell therapies more accessible. These treatments have been
Pharmaceutical News
Novartis Strengthens Case for Full Approval of Vanrafia in Kidney Disease
In 2026, Novartis is making progress in getting full approval for their drug Vanrafia to treat IgA nephropathy, a type
Sanofi Gets a New Leader: What This Means for the Future
Sanofi, a big French drug company, has a new CEO. Paul Hudson is stepping down after six years. During his
New Group Aims to Boost Investment in Europe’s Health and Biotech Startups
A new group called the European Life Sciences Coalition has started in Brussels. Its goal is to encourage more investment
New Company Aims to Fight Cancer with Personalized Vaccines
A company called Kahimmune Therapeutics, which focuses on cancer treatments that boost the immune system, has made a special deal
Big Pharma’s Race to Create the Next Big Weight Loss Drug
A fierce competition is happening among pharmaceutical companies to create the next groundbreaking weight loss drug. While the first generation
Pharmaceutical News
New Medicine Coating Without Titanium Dioxide Developed
Scientists have found a new way to coat a common medicine called drotaverine hydrochloride without using titanium dioxide (TiO2). This
Pharma Companies Look Ahead to 2026 with Hope and Strategy
With many challenges facing the drug industry in 2026, a bit of hope can make a big difference. While leaders
Biotech Company Eikon Therapeutics Raises $381 Million in Stock Market Debut
Eikon Therapeutics, a well-known biotech startup with big-name backers, announced on Wednesday that it has raised $381 million by selling